3 Dividend Stocks for April 2026
Why It Matters
These moat‑protected dividend growers combine rising payouts with valuation discounts, offering income investors attractive yield and upside potential while highlighting tax and ADR considerations.
Key Takeaways
- •Air Products raised dividend 1% to $1.81, 44-year streak.
- •Morningstar values Air Products at $39, below market price.
- •Fidelity National increased dividend 10% to $0.44, trading below $85 fair value.
- •RO Holding's ADR dividend rose to $159, reflecting Swiss franc payout.
- •All three firms possess economic moats, appealing to income investors.
Summary
Morningstar’s dividend‑stock video spotlights three recent dividend raisers—Air Products & Chemicals, Fidelity National Information Services, and Swiss‑based Roche Holding (RO). Each company carries a Morningstar economic moat rating, signaling durable competitive advantages, and all are positioned as potential income generators despite mixed valuation signals.
Air Products, a global industrial‑gas leader, lifted its quarterly payout 1% to $1.81, extending a 44‑year dividend streak. Morningstar assigns it a wide moat and a $39 fair‑value target, implying modest upside. Fidelity National, a bank‑technology provider, boosted its dividend 10% to $0.44 and is trading well below its $85 intrinsic value, reflecting a transition toward a cash‑cow model. Roche, the biotech and diagnostics giant, raised its ADR dividend to $159, with payouts denominated in Swiss francs and subject to ADR fees and withholding taxes.
The analysts highlight concrete metrics: Air Products’ risk‑management overhaul, Fidelity’s deal‑driven cash flow conversion, and Roche’s unique position to drive personalized, cost‑effective healthcare. They caution U.S. investors to account for tax and fee considerations on Roche’s ADRs.
For income‑focused portfolios, the trio offers a blend of stable cash flow, moat‑backed resilience, and potential price appreciation. Investors should weigh the valuation gaps against dividend growth prospects and factor in tax implications, especially for foreign‑listed ADRs.
Comments
Want to join the conversation?
Loading comments...